Bejar Rafael 4
4 · Aptose Biosciences Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Bejar Rafael
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-01-04+343,000→ 343,000 totalExercise: $4.37Exp: 2031-01-04→ Common Shares (343,000 underlying)
Footnotes (1)
- [F1]The options were granted on January 4, 2021. One-half of the options vest on January 4, 2022. The remaining one-half of the options vest as follows: 1/3 on January 4, 2023; 1/3 on January 4, 2024; and 1/3 on January 4, 2025.